Among these, FTO-43N emerged as a lead compound, effectively elevating m6A and m6Am levels in gastric cancer cells, ultimately exerting anti-cancer effects by regulating the Wnt/PI3K-Akt signaling pathway (166). Here, FTO is linked to cancer.